Melanomas have a high frequency of mutant BRAF mutations, and in papillary thyroid cancer, expression of mutant BRAF is associated with inhibition of MST1/2 kinases (Lee et al., 2011); it would be interesting to determine whether this is also the case in melanoma. The gene discussed is BRAF; the disease is melanoma.